Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1. (Q54588963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Mechanisms mediating the diuretic and natriuretic actions of the incretin hormone glucagon-like peptide-1 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

Adriana Castello Costa Girardi

1 February 2020

author

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

6

Gerhard Malnic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Renato O Crajoinas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Felipe T Oricchio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Thaissa D Pessoa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Bruna P M Pacheco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lucília M A Lessa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

18 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

F355-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21593184%20AND%20SRC:MED&resulttype=core&format=json

Rapid microplate method for PAH estimation

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

More choices than ever before: emerging therapies for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Regulation of Na+/H+ exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Regulatory binding partners and complexes of NHE3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Biologic actions and therapeutic potential of the proglucagon-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Diabetes mellitus and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Binding specificity and signal transduction of receptors for glucagon-like peptide-1(7-36)amide and gastric inhibitory polypeptide on RINm5F insulinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Role of dipeptidyl peptidase IV in regulating activity of Na+/H+ exchanger isoform NHE3 in proximal tubule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Exendin-4 has an anti-hypertensive effect in salt-sensitive mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Use of phospho-specific antibodies to determine the phosphorylation of endogenous Na+/H+ exchanger NHE3 at PKA consensus sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

A standard nomenclature for structures of the kidney. The Renal Commission of the International Union of Physiological Sciences (IUPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Exenatide improves hypertension in a rat model of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

S3226, a novel inhibitor of Na+/H+ exchanger subtype 3 in various cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010

Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00729.2010